Gemini Therapeutics
Signal active
Organization
Contact Information
Overview
Gemini Therapeutics is a precision medicine company focused on genetically defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. Their therapeutic candidates are matched to molecular abnormalities found in patients with high clinical needs and our broad multimodal pipeline includes monoclonal antibodies, recombinant proteins, and gene therapies. Launched with funding from leading life science investors and powered by academic partnerships around the world, they are developing a series of potentially first-in-class therapeutics.
About
Industries
Biotechnology, Biopharma, Health Diagnostics
Founded
2015
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Gemini Therapeutics headquartered in United States, North America, operates in the Biotechnology, Biopharma, Health Diagnostics sector. The company focuses on Biotechnology and has secured $5.0B in funding across 36 round(s). With a team of 11-50 employees, Gemini Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Gemini Therapeutics, raised $2.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
3
Investors
3
Lead Investors
0
Total Funding Amount
$139.5M
Details
2
Gemini Therapeutics has raised a total of $139.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Early Stage Venture | 42.5M | ||
| 2016 | Seed | 2.0M |
Investors
Gemini Therapeutics is funded by 34 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Stephen Squinto | - | FUNDING ROUND - Stephen Squinto | 2.0M |
| Carl L. Gordon | - | FUNDING ROUND - Carl L. Gordon | 2.0M |
| Gemini Therapeutics | - | FUNDING ROUND - Gemini Therapeutics | 2.0M |
| OrbiMed | - | FUNDING ROUND - OrbiMed | 2.0M |
Recent Activity
There is no recent news or activity for this profile.